| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention concerns medicine, namely pharmacology, hypoglycemic agents influencing the glucose blood content in treating the diseases associated with metabolic disorders, such as pancreatic diabetes. The agent expressing hypoglycemic activity, characterised by that it contains N-isopropylamide-2-(1-phenylethyl)aminoethanesulphacid hydrochloride in effective amount. ^ EFFECT: invention renders more expressed hypoglycemic action. ^ 2 cl, 3 ex, 5 tbl |
